Connectez-vous pour accéder aux recommandations de stratégie gagnante.
Se connecterPassez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.
Se connecter16 exigences dans 5 catégories
Inscrivez-vous pour consulter les exigences et l'analyse complètes
9 documents disponibles avec des résumés IA
This document is a draft contract outlining the special conditions for the purchase and sale of reagents and additional supplies for tumor sequencing tests, including the acquisition of a new generation sequencing laboratory system for use.
This document outlines the technical specifications for reagents and additional supplies for tumor sequencing tests, including a price offer table that suppliers must complete according to detailed requirements for the provided laboratory system.
This document is a declaration form requiring the supplier to identify its responsible persons (board/supervisory board members) in accordance with Article 46 of the Public Procurement Law, and to confirm the absence of exclusion grounds for these individuals.
This document is a mandatory supplier's declaration form for legal entities, confirming their compliance with regulatory provisions and participation in the tender, requiring company details and an authorized signature.
This document outlines the general terms and conditions for the goods purchase-sale agreement, defining key concepts and the legal framework for the future contract.
This document is a mandatory declaration form for suppliers to confirm that their offered goods/services and their own operations do not pose a threat to national security, as per Lithuanian public procurement law.
This document outlines the general conditions for the open competition, detailing supplier qualification requirements, grounds for exclusion, proposal preparation and submission procedures, evaluation criteria, and contract signing terms for reagents and additional tools for tumor sequencing tests.
This European Single Procurement Document (ESPD) is a mandatory form for bidders to declare their compliance with exclusion and selection criteria, providing essential company information for the tender for reagents and additional supplies for tumor sequencing tests.
This tender from Kauno klinikos seeks suppliers for laboratory reagents and additional supplies for tumor sequencing tests, including the acquisition of a new generation sequencing laboratory system for use, with an estimated value of 3.66 million Euros.
Inscrivez-vous pour consulter les résumés et l'analyse des documents
This tender demonstrates good foundational elements with clear procedural definitions and comprehensive documentation, but is significantly hampered by the critical absence of explicit evaluation criteria, impacting clarity, completeness, and fairness. It also lacks focus on sustainability aspects.
The tender clearly defines the procedure type (Open, 2014/24/ES) and uses an appropriate CPV code. The inclusion of an ESPD and references to national procurement law indicate an intent for compliance. However, the absence of a clear reveal date for the tender notice is a minor transparency concern. The contradiction between 'Status: active' and the automated check's 'Tender suspended' flag is noted, but 'active' is assumed to be correct.
The tender description directs bidders to a specific appendix for technical specifications and pricing, which is good. AI-extracted requirements are well-categorized. However, a significant concern is the explicit flag 'No evaluation criteria specified'. While a document summary mentions evaluation criteria, their absence from the detailed requirements makes it difficult for bidders to understand how their proposals will be assessed, leading to ambiguity.
Basic information, financial details, timelines, and location are adequately provided. All listed documents are present, and required forms are identified. The main gap in completeness, however, is the lack of explicitly detailed evaluation criteria, which are fundamental for a comprehensive tender package.
The tender promotes fairness through disclosed value, implied document access, and e-procurement capabilities. However, the absence of clearly specified evaluation criteria significantly undermines the objectivity and transparency of the process, making it challenging for bidders to prepare competitive and relevant proposals. The phrasing regarding 'the provided laboratory system' is noted but not flagged as tailoring without further detail, especially given the context of acquiring a new system.
Electronic submission is indicated by 'E-Procurement'. The contract duration is clearly specified. However, the tender lacks an explicit contract start date and does not specify the financing source beyond the estimated value. Document URLs are not explicitly provided in the summary, but documents are listed as available.
Most key fields are populated, and dates are logical. A notable inconsistency exists between the 'Status: active' in the basic information and the 'Tender suspended' flag in the automated check results. Assuming 'Status: active' is the correct and primary information, this remains an internal data quality issue in the provided analysis rather than a tender flaw.
The tender does not include any explicit criteria or considerations for green procurement, social aspects, or innovation in the procurement process itself. While the subject matter (new generation sequencing) is innovative, the tender does not leverage this for sustainable procurement practices.
Inscrivez-vous pour consulter les exigences et l'analyse complètes
Aucune carte de crédit requise • Configuration en 2 minutes
Bonjour ! Je suis votre assistant IA pour cet appel d'offres. Je peux vous aider à comprendre les exigences, les délais, les critères d'admissibilité et vous fournir des informations stratégiques.
Aucune carte de crédit requise